F
Francesco E. Pontieri
Researcher at Sapienza University of Rome
Publications - 140
Citations - 8326
Francesco E. Pontieri is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Parkinson's disease & Dopaminergic. The author has an hindex of 35, co-authored 128 publications receiving 7542 citations. Previous affiliations of Francesco E. Pontieri include National Institutes of Health & University of Cagliari.
Papers
More filters
Journal ArticleDOI
Hippocampal abnormalities and memory deficits in Parkinson disease A multimodal imaging study
Giovanni Augusto Carlesimo,Fabrizio Piras,Francesca Assogna,Francesco E. Pontieri,Carlo Caltagirone,Gianfranco Spalletta +5 more
TL;DR: Data confirm that the declarative memory impairment in patients with PD without dementia may be predicted by the rate of microstructural alterations in the hippocampal formation as detected by diffusion tensor imaging analysis.
Journal ArticleDOI
Neuropharmacology and behavior in planarians: Translations to mammals
TL;DR: Findings indicate that interactions between discrete neurotransmitter-receptor systems occur very early along phylogeny, although they may have evolved from very fundamental behaviors, such as motor activity in planarian, to more complex and integrated functions in vertebrates.
Journal ArticleDOI
The recognition of facial emotion expressions in Parkinson's disease
TL;DR: The clinical characteristics and neural structures involved in the recognition of specific facial emotion expressions, and the plausible role of dopamine transmission and dopamine replacement therapy in these processes are reviewed.
Journal ArticleDOI
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression
Letterio Morgante,Carlo Colosimo,Angelo Antonini,Roberto Marconi,Giuseppe Meco,Massimo Pederzoli,Francesco E. Pontieri,Giulio Cicarelli,Giovanni Abbruzzese,Salvatore Zappulla,Silvia Ramat,M. Manfredi,Edo Bottacchi,Michele Abrignani,Alfredo Berardelli,Autilia Cozzolino,Claudio Paradiso,Danilo De Gaspari,Francesca Morgante,Paolo Barone +19 more
TL;DR: Psychotic type symptoms may occur in the early stages of PD although less frequently than in later stages, and beyond dopaminergic treatment, there are disease related factors, such as disease severity and the occurrence of cognitive and depressive symptoms, which may underlie the onset of psychotic type symptoms from the earliest stages.
Journal ArticleDOI
The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders
TL;DR: Findings suggest that PBL may prove a cellular tool with which to identify the derangement of DA transmission in neuropsychiatric diseases, as well as to monitor the effects of pharmacological treatments.